Case Study: Independent Home Infusion Pharmacy Achieves NABP Accreditation and Medicare Enrollment in 9 Months
Situation Overview
An independent home infusion pharmacy operating in a mid-sized metropolitan market had been providing antibiotic and antifungal infusion therapy to patients for over five years, billing exclusively through commercial insurance contracts. As the local hospital system — a major referral source — began transitioning more patients to Medicare Advantage plans with home infusion benefits, the pharmacy found itself unable to bill for an increasing share of its patient population. The pharmacy contacted IHS to pursue NABP Home Infusion Therapy Pharmacy Accreditation and Medicare Part B enrollment as a home infusion therapy supplier.
Challenges
- 24/7 coverage structure: The pharmacy operated with three pharmacists on a scheduled rotation, but its on-call coverage relied on informal arrangements without documentation, defined escalation procedures, or backup protocols. NABP's 24/7 requirement needed formalized infrastructure, not just a phone rota.
- USP 797 documentation gaps: The pharmacy had a clean room and followed USP 797 practices in its compounding operations, but environmental monitoring documentation was inconsistent — some months had complete records, others had gaps. Beyond-use dating policy was not clearly documented for all product categories.
- Patient education program formalization: Patient education was delivered verbally by a clinical pharmacist at the time of therapy initiation. There was no standardized curriculum, no competency assessment checklist, and no documentation system to verify that each patient or caregiver had received and understood the required training.
- Quality assurance program: The pharmacy tracked dispensing errors internally, but the tracking system was a spreadsheet with no defined review frequency, no CAPA process, and no committee structure for analyzing trends.
- Medicare enrollment sequencing: The pharmacy was unfamiliar with the sequencing of NABP accreditation and Medicare Part B enrollment as a home infusion therapy supplier. Missteps in enrollment sequencing can create delays of months.
IHS Approach
Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — structured the engagement around the pharmacy's target Medicare enrollment date and worked backward to sequence the accreditation readiness workstreams.
24/7 Coverage Infrastructure
IHS developed a formal pharmacist on-call policy that defined coverage rotation responsibilities, backup pharmacist requirements, escalation procedures for clinical emergencies, documentation of on-call handoffs, and performance expectations for on-call response times. The policy was reviewed and signed by all three pharmacists. A call log system was implemented to document all after-hours contacts and their resolution. IHS also advised the pharmacy on backup coverage arrangements with a clinical pharmacist contractor for periods when internal coverage might be disrupted.
USP 797 Documentation Remediation
IHS reviewed 18 months of environmental monitoring data, identified the months with incomplete records, and worked with the pharmacy's compounding supervisor to reconstruct documentation where possible and implement a prospective monitoring tracking system that made gaps immediately visible. A revised environmental monitoring SOP with daily, weekly, and monthly record requirements was developed. Beyond-use dating policy was formalized and integrated into the compounding SOP for all product categories, including room-temperature-stable antibiotics, refrigerated products, and frozen preparations.
Patient Education Program
IHS developed a structured patient education curriculum for the pharmacy's primary therapy categories — IV antibiotics, antifungals, and hydration therapy. The curriculum included written patient education materials at a 6th-grade reading level, a pharmacist-delivered education checklist, and a patient/caregiver competency demonstration checklist covering infusion technique, pump operation, catheter site care, and adverse event response. A documentation form was developed for the patient record confirming education delivery and competency assessment for each patient.
Quality Assurance Program
IHS replaced the pharmacy's spreadsheet-based error tracking with a structured QA program including a monthly QA committee review process, standardized near-miss and adverse event reporting forms, CAPA documentation templates, and a quarterly outcome metrics dashboard. The QA committee — comprising the pharmacist-in-charge, operations manager, and a clinical staff representative — began meeting monthly three months before the NABP application was submitted, generating two months of QA data prior to review.
Medicare Enrollment Guidance
IHS advised the pharmacy on the sequencing of NABP accreditation submission and Medicare Part B enrollment as a home infusion therapy supplier, including the National Supplier Clearinghouse application process, NPI requirements, and the relationship between accreditation grant and enrollment approval timing. The pharmacy submitted its Medicare enrollment application within one week of receiving NABP accreditation.
Outcomes
- NABP Home Infusion Therapy Pharmacy Accreditation granted in month 9 of the engagement
- Zero deficiency findings in the NABP accreditation review
- Medicare Part B enrollment as a home infusion therapy supplier approved within 10 weeks of accreditation grant
- 24/7 on-call coverage infrastructure formalized, documented, and operational
- USP 797 documentation current and complete; no gaps in prospective monitoring records
- Patient education curriculum deployed for all therapy categories; all existing patients documented
- QA program operational with two months of committee meeting records prior to NABP review
Key Lessons
Informal practices are not accreditable practices. This pharmacy was delivering high-quality home infusion therapy by every clinical measure. The gaps were not in clinical performance but in documentation and formalization. Accreditation does not evaluate whether your pharmacy is good — it evaluates whether your pharmacy can prove it. The documentation infrastructure that supports accreditation also supports quality improvement, error prevention, and risk management long after the accreditation review is complete.
USP 797 documentation requires continuous discipline. Retrospective environmental monitoring reconstruction is possible in limited circumstances, but it is not a substitute for a prospective system with built-in accountability. Every home infusion pharmacy should have a monitoring log system that makes incomplete records visible immediately — not at the end of a quarter or at accreditation review time.
Sequencing matters for Medicare enrollment. The order of operations for NABP accreditation and Medicare enrollment as a home infusion therapy supplier is specific. Getting the sequence wrong — such as submitting the Medicare enrollment application before accreditation is granted — adds avoidable delays to the revenue start date. IHS provides enrollment sequencing guidance as a standard component of every home infusion accreditation engagement.
Ready to Expand Your Home Infusion Pharmacy into Medicare?
IHS provides the structured consulting expertise to achieve NABP Home Infusion Therapy Pharmacy Accreditation and navigate Medicare Part B enrollment as a home infusion therapy supplier. Schedule a Free Discovery Session with Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC.